Unknown

Dataset Information

0

Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists.

ABSTRACT: N-(5-Bromo-3-methoxypyrazin-2-yl)-5-chlorothiophene-2-sulfonamide 1 was identified as a hit in a CCR4 receptor antagonist high-throughput screen (HTS) of a subset of the AstraZeneca compound bank. As a hit with a lead-like profile, it was an excellent starting point for a CCR4 receptor antagonist program and enabled the rapid progression through the Lead Identification and Lead Optimization phases resulting in the discovery of two bioavailable CCR4 receptor antagonist candidate drugs.

SUBMITTER: Kindon N 

PROVIDER: S-EPMC5601455 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

<i>N</i>-(5-Bromo-3-methoxypyrazin-2-yl)-5-chlorothiophene-2-sulfonamide <b>1</b> was identified as a hit in a CCR4 receptor antagonist high-throughput screen (HTS) of a subset of the AstraZeneca compound bank. As a hit with a lead-like profile, it was an excellent starting point for a CCR4 receptor antagonist program and enabled the rapid progression through the Lead Identification and Lead Optimization phases resulting in the discovery of two bioavailable CCR4 receptor antagonist candidate dru  ...[more]

Similar Datasets

Unknown Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists.
| S-EPMC3369735 | biostudies-literature
Unknown Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist.
| S-EPMC4007836 | biostudies-other
Unknown Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides.
| S-EPMC3375398 | biostudies-literature
Unknown Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9).
| S-EPMC7488287 | biostudies-literature
Unknown Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists.
| S-EPMC6121070 | biostudies-literature
Unknown Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2.
| S-EPMC6580541 | biostudies-literature
Unknown Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus.
| S-EPMC4867477 | biostudies-literature
Unknown Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.
| S-EPMC4027753 | biostudies-literature
Unknown Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.
| S-EPMC4025788 | biostudies-other
Unknown Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
| S-EPMC4007909 | biostudies-other